↓ Skip to main content

SEPT6_TRIM33 Gene Fusion and Mutated TP53 Pathway Associate With Unfavorable Prognosis in Patients With B-Cell Lymphomas

Overview of attention for article published in Frontiers in oncology, December 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
14 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
SEPT6_TRIM33 Gene Fusion and Mutated TP53 Pathway Associate With Unfavorable Prognosis in Patients With B-Cell Lymphomas
Published in
Frontiers in oncology, December 2021
DOI 10.3389/fonc.2021.765544
Pubmed ID
Authors

Haiying Fu, Huarong Zhou, Yanyan Qiu, Jianfei Wang, Zhiming Ma, Hongping Li, Feng Zhang, Chenxi Qiu, Jianzhen Shen, Tingbo Liu

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 14 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 2 14%
Librarian 1 7%
Unspecified 1 7%
Student > Ph. D. Student 1 7%
Student > Master 1 7%
Other 0 0%
Unknown 8 57%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 3 21%
Medicine and Dentistry 2 14%
Biochemistry, Genetics and Molecular Biology 2 14%
Environmental Science 1 7%
Unknown 6 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 December 2021.
All research outputs
#15,181,325
of 25,392,582 outputs
Outputs from Frontiers in oncology
#4,558
of 22,436 outputs
Outputs of similar age
#237,155
of 514,062 outputs
Outputs of similar age from Frontiers in oncology
#247
of 1,364 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,436 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 514,062 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 1,364 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.